SPRINT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Sprint Bioscience is a research company. The company develops drug candidates that can fight cancer individually or in combination with other drugs. The company has a portfolio of projects that are focused on attacking parts of the processes of cancer cells. The business model is based on a project portfolio and developing projects in parallel in the preclinical phase and then entering into licensing agreements with the global pharmaceutical industry. The company is headquartered in Huddinge.
Lue lisääOsavuosikatsaus Q2'26
Osavuosikatsaus Q3'26
Vuosikatsaus '26
Liikevaihto milj.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.